Homburger has appointed three new partners as of 1 January 2024 who will reinforce its teams of corporate and M&A. Anna Peter (pictured centre), Margrit Marti (pictured right) and Miguel Sogo (pictured left) are based
Niederer Kraft Frey advised Transgourmet Switzerland, the second biggest wholesaler in Europe, on the acquisition of POMONA SUISSE. With this acquisition, the company is strengthening its expertise in innovative product ranges as well as in
Fahrzeug-Werke LUEG, one of the largest mobility providers in Germany and a renowned sales and service partner of the Daimler group, has acquired the Mercedes-Benz dealership Elite Autocenter in Wilderswil near Interlaken, in the canton
The Swiss FinTech Start-Up LEND has successfully completed a Series C financing round of CHF 2,5 million. In the course of the financing round, crowd investors have been issued new shares in the form of ledger-based
Wenger Vieli, a prominent law firm with a history of dynamic leadership changes every 1.5 years, has announced the appointment of Pascal Honold as the new Managing Partner, effective January 1, 2024. Honold has extensive expertise in the
Altenburger advised Kylian Mbappé in a long-term strategic partnership with Loewe. Soccer superstar will be the worldwide brand ambassador of the brand, a global player in the luxury segment of the consumer electronics industry. Mbappé
Niederer Kraft Frey advised Calibre Scientific on the acquisition of Bioreba, a Swiss biotech company and provider of plant pathogen diagnostic test kits and services, selling to diagnostic labs, universities, public and private research institutions
Proteomedix, a Swiss private, commercial-stage diagnostics oncology company and Water Biotech are forming together a company called Onconetix. The transaction is implemented by the acquisition of Proteomedix for an all stock consideration. Onconetix’s commercial
AXA Investment Managers Schweiz is planning to merge three real estate funds. The new “AXA Real Estate Fund Switzerland” is set to become the largest real estate fund – based on NAV – for pension fund investors
AC Immune, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative diseases listed on the Nasdaq completed an underwritten offering of 14.3 million of its common shares at a price of USD 3.50 per
